Former heavyweight champion Joseph Parker has maintained that a positive drug test, which led to his temporary suspension from boxing, was the result of inadvertent exposure to cocaine through his nutritionist. The claim was disclosed in a statement from UK Anti-Doping (UKAD) and has now been corroborated by the anti‑doping authority, which lifted Parker's provisional ban and allowed him to return to competition.
The issue first emerged after Parker’s unexpected loss to Britain’s Fabio Wardley on 25 October 2025 in London. During a routine UKAD out‑of‑competition test conducted shortly after the bout, analysts detected benzoylecgonine – the primary metabolite of cocaine – in Parker’s urine sample.
This finding was recorded as an adverse analytical finding (AAF) and triggered a provisional suspension that could have extended up to two years under the World Anti‑Doping Code. Parker has consistently denied any intentional use of prohibited substances.
In a press release issued on Wednesday, he announced that the suspension had been removed and that he intended to step back into the ring in the near future. The following day, UKAD issued a formal statement confirming that Parker was cleared to resume his boxing career and outlining the rationale behind the decision.
According to UKAD, on 6 March 2026 Parker supplied documentation asserting that the benzoylecgonine detected in his sample was not the product of personal consumption but rather the consequence of exposure to cocaine used by his nutritionist. The nutritionist, who had been working with Parker since April 2023, admitted to being a regular cocaine user and disclosed that he had consumed the drug daily during the week leading up to the 25 October fight.
UKAD requested additional information from Parker between 14 April and 3 June 2026 to verify his account. In response, Parker reiterated that his relationship with the nutritionist began in early 2023 and that he had no direct involvement with the drug. The anti‑doping body then consulted an independent scientific expert to evaluate whether the ingestion could be classified as out‑of‑competition, which would mitigate the severity of any sanction. The expert’s opinion, received on 15 June 2026, concluded that the most plausible scenario was that Parker’s exposure to cocaine occurred before the competition window closed at 23:59 on 24 October 2025.
Consequently, the ingestion was deemed unrelated to sporting performance. On 22 June 2026, UKAD communicated its satisfaction with the expert’s assessment and announced that Parker’s provisional suspension was lifted with immediate effect.
The authority also proposed a three‑month period of ineligibility, which it considered already served, as the formal sanction for the anti‑doping rule violation. The scientific report offered two possible mechanisms for the presence of benzoylecgonine in Parker’s urine. First, it suggested that contamination could have occurred through food or supplements prepared by the nutritionist, who had openly admitted to cocaine use.
Second, the expert could not entirely rule out the possibility that Parker had ingested a larger, pharmacologically active dose of cocaine, with the detected metabolite representing the tail end of that exposure. The report emphasized that while contamination was a credible explanation, the evidence was not definitive enough to exclude all other scenarios. As a result of the anti‑doping findings, the outcome of Parker’s fight with Wardley has been altered.
The original 11th‑round stoppage loss, which was recorded as a knockout defeat for Parker, is now officially listed as a loss by disqualification. This administrative change reflects the fact that the bout’s result is being retroactively affected by the doping violation.
Parker’s career trajectory provides context for the significance of this episode. He captured the heavyweight world title in 2018 by defeating Anthony Joshua, but lost the belt later that year. After a heavy defeat to Joe Joyce in 2022, Parker rebounded impressively, stringing together six consecutive victories, including notable wins over former champion Deontay Wilder and Chinese contender Zhilei Zhang.
Those successes earned him the WBO interim title and positioned him as the mandatory challenger for the undisputed champion Oleksandr Usyk. In early 2024, Parker was slated to face IBF champion Daniel Dubois in February. However, Dubois fell ill just days before the scheduled bout, prompting its cancellation.
Undeterred, Parker elected to risk his mandatory challenger status by accepting a fight against Wardley, a decision that ultimately backfired due to the loss and subsequent doping controversy. Looking ahead, Parker’s reinstatement by UKAD opens the door for a potential comeback. The boxer has expressed eagerness to return to training and to line up another high‑profile fight, possibly reclaiming his position among the heavyweight elite.
The anti‑doping saga, while a setback, also highlights the complexities athletes face when surrounding personnel engage in illicit behavior. It underscores the importance of rigorous oversight of support staff and the need for athletes to maintain strict control over everything that enters their bodies. In summary, Joseph Parker’s positive test for benzoylecgonine has been attributed to accidental exposure via a cocaine‑using nutritionist, according to UKAD’s investigation and independent scientific analysis. The provisional suspension has been lifted, a three‑month sanction deemed served, and the boxer is now cleared to compete again.
The case serves as a cautionary tale about the far‑reaching implications of a support team’s personal choices on an athlete’s career and reputation.